iCo Therapeutics Inc

Website Links

Description

Mr. Rae is President and CEO of iCo Therapeutics, Inc., an ocular development company he co-founded in 2005. Andrew has spent a decade in the biotechnology industry, formerly as CFO with Ability Biomedical Corporation (Irvine CA, Vancouver BC), acquired by Medarex, Inc. in 2004. Mr. Rae has also served as Vice President, Finance & Corporate Affairs at Active Pass Pharmaceuticals (Vancouver BC). In his various roles , Mr.

Dr. Lasezkay is the president of Turning Point Consultants, a consultancy practice that advises life sciences companies on strategy and business development. He is a former Corporate Vice President of Corporate Development at Allergan, a global pharmaceutical and medical aesthetics company. He also has extensive experience in hospital pharmacy practice, clinical pharmacokinetics consultation, clinical drug research and pharmacy education. Dr. Lasezkay earned B.S.

Dr Richard W. Barker was Director General of the Association of the British Pharmaceutical Industry from August 2004 to May 2011. Prior to joining APBI , Dr. Barker was the Founder and President of New Medicine Partners, CEO of iKnowMed, Chief Executive of Chiron Diagnostics, General Manager of IBM's Worldwide Healthcare Solutions division, and leader of McKinsey's European healthcare practice.

Products & services

Similar companies nearby